Published Date : Feb 01, 2016
ALBANY, New York, Feb 01, 2016: A new market study on the global endovascular aneurysm repair (EVAR) market has been added to the huge repository of MarketResearchReports.biz. The research report, titled “Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition”, provides a comprehensive research and an unbiased reports of the current status and the future outlook of the global EVAR market.
It also offers an overview of the historical performance of the global EVAR market analyzing various factors, driving the growth of the market. The report also studies recent trends and restraining factors that have influenced the growth of this market.
Endovascular aneurysm repair (EVAR) is a treatment method used for treating people suffering from abdominal aortic aneurysm (AAA), which is a condition where an abnormal enlargement or a localized bulging of the abdominal aorta happens. AAA occurs mostly in males ageing more than 65 years, thus, the prime end user of EVAR are geriatric males, states the research report.
The research report further states that this treatment method is a minimally invasive alternative to major open surgeries to repair AAAs that reduces the recovery period while potentially improves the survival rate. Endovascular procedures are aimed to decrease the morbidity as well as the mortality rate of AAA patients after the treatment.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/516408
According to the market report, the increasing usage of percutaneous EVAR for the treatment of AAA is the latest trend among medical professionals. The efficiency of EVAR method compared to the traditional open surgery has added significantly to its popularity, which is another major factor behind the growth of this market. The rising base of the geriatric population across the world and the healthcare expenditure associated with them are other prominent factors, expected to propel the global market for EVAR significantly during the forecast period.
On the other hand, post-surgery complications such as endoleaks and endograft migration, together with increasing number of rules and policies regulations imposed on the usage of EVAR methods by regulatory authorities such as the U.S. FDA, are likely to restrict the global EVAR market from growing steadily over the forecast period. However, the ongoing clinical studies and the technical development in the field of EVAR therapy are projected to boost the worldwide EVAR market in the coming years, says the market study.
The report also presents the competitive landscape of the global EVAR market by analyzing the company profiles of major market participants. Medtronic Inc., Lombard Medical, and TriVascular are the top three companies operating in the worldwide EVAR market, states the research report.
The main objective of this market study is to offer a better understanding of the global EVAR market to participants operating in this market in order to assist them in achieving a competitive edge over their peers.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org